Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?

Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?

Item
http://www.wikidata.org/entity/Q38209789
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor MicroenvironmentsQuantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma.Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.Biotinylated N-Acetyllactosamine- and N,N-Diacetyllactosamine-Based Oligosaccharides as Novel Ligands for Human Galectin-3.Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.Enzymatic Synthesis of N-Acetyllactosamine (LacNAc) Type 1 Oligomers and Characterization as Multivalent Galectin Ligands.Galectin-7 in Epithelial Homeostasis and Carcinomas.Role of MSC-derived galectin 3 in the AML microenvironment.
P2860

Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?

Item
http://www.wikidata.org/entity/Q38209789
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
@en
type
label
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
@en
prefLabel
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
@en
P2093
P2860
P304
P31
P356
10.3109/08830185.2014.911855
P433
P478
P577
P698
P921